Award
National Institute of Allergy and Infectious Diseases 5P01AI100148-13
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
Recipient
California Institute of Technology, Pasadena, CA, United States
Award Amount
$872,925.00
Ceiling
$872,925.00
Awarded
January 28, 2026
Identifier
5P01AI100148-13
This NIH-funded project focuses on developing immunogens to elicit broadly neutralizing antibodies against HIV-1 to improve vaccine efficacy through sequential immunization strategies and immunogen design.
Description
The project aims to develop immunization strategies that elicit broadly neutralizing antibodies (bNAbs) against HIV-1. The research focuses on sequential immunization regimens, immunogen design, and understanding off-target responses to improve vaccine efficacy.